Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease : Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 1995
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131344/
http://dx.doi.org/10.1016/0264-410X(95)90208-7
_version_ 1783517217371979776
collection PubMed
description
format Online
Article
Text
id pubmed-7131344
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71313442020-04-08 Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease : Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995 Vaccine Article Published by Elsevier Ltd. 1995 2003-10-11 /pmc/articles/PMC7131344/ http://dx.doi.org/10.1016/0264-410X(95)90208-7 Text en Copyright © 1995 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease : Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995
title Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease : Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995
title_full Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease : Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995
title_fullStr Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease : Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995
title_full_unstemmed Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease : Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995
title_short Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease : Max Planck Soc; German Cancer Res. Inst. Eur 633 313; 11 January 1995
title_sort pathogen strain borrelia burgdorferi zs7 (dsm 5527); for the production of passive antibodies for the treatment of lyme disease : max planck soc; german cancer res. inst. eur 633 313; 11 january 1995
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131344/
http://dx.doi.org/10.1016/0264-410X(95)90208-7

Ejemplares similares